コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ant metabolites, such as the reduced form of nicotinamide adenine dinucleotide.
2 P-ribose)polymerase 1 activation, exhausting nicotinamide adenine dinucleotide and adenosine triphosp
3 a common intermediate in the biosynthesis of nicotinamide adenine dinucleotide and its derivatives in
4 skeletal proteins, and loss of intracellular nicotinamide adenine dinucleotide and nicotinamide adeni
5 thesis of RNA with NADH (the reduced form of nicotinamide adenine dinucleotide) and FAD (flavin adeni
6 primarily SAM (S-adenosyl methionine), NAD (nicotinamide adenine dinucleotide), and FAD (flavin aden
9 ctate, with concomitant oxidation of reduced nicotinamide adenine dinucleotide as the final step in t
10 nicotinamide adenine dinucleotide to reduced nicotinamide adenine dinucleotide, as a result of oxidat
11 netics of the signal transducing reaction of nicotinamide adenine dinucleotide at CNTs accounted for
12 functional capillary density: 573+/-13cm/cm; nicotinamide adenine dinucleotide autofluorescence: 56+/
13 functional capillary density: 469+/-22cm/cm; nicotinamide adenine dinucleotide autofluorescence: 61+/
14 ry density: 379+/-20cm/cm;), tissue hypoxia (nicotinamide adenine dinucleotide autofluorescence: 77+/
17 show that NHDs are NAD(+) (oxidized form of nicotinamide adenine dinucleotide) binding domains that
20 of extracellular adenosine triphosphate and nicotinamide adenine dinucleotide, both pathways converg
21 y to the Shp promoter, which was enhanced by nicotinamide adenine dinucleotide, but not nicotinamide
23 cient oxidative phosphorylation, diminishing nicotinamide adenine dinucleotide concentrations and imp
24 europathy (LHON) caused by a mutation in the nicotinamide adenine dinucleotide dehydrogenase subunit
25 Fe-S center within Complex I (Ndufs1, NADH [nicotinamide adenine dinucleotide] dehydrogenase [ubiqui
26 ease in the activity of the NAD(+) (oxidized nicotinamide adenine dinucleotide)-dependent deacetylase
28 mutant mouse models to demonstrate that the nicotinamide adenine dinucleotide-dependent (NAD-depende
32 otide phosphate-dependent IDH1 and IDH2, and nicotinamide adenine dinucleotide-dependent IDH3) contri
33 IRT1), the most conserved mammalian oxidized nicotinamide adenine dinucleotide-dependent protein deac
35 d the recently discovered DNA damage-induced nicotinamide adenine dinucleotide(+) depletion to underl
36 ial mapping, analysis of lactate production, nicotinamide adenine dinucleotide epifluorescence, lacta
37 ease in mitochondrial calcium content and in nicotinamide adenine dinucleotide fluorescence following
38 zoles promote neuronal survival by enhancing nicotinamide adenine dinucleotide flux in injured neuron
39 measuring the rates of production of reduced nicotinamide adenine dinucleotides from 91 potential ene
40 catenation of FeS and glycerol-dehydrogenase/nicotinamide-adenine-dinucleotide (GlDH-NAD(+)) apoenzym
43 ontaining 1) is responsible for depletion of nicotinamide adenine dinucleotide in its oxidized form (
44 ins of NLRs are enzymes capable of degrading nicotinamide adenine dinucleotide in its oxidized form (
45 oxidase that helps to regulate intracellular nicotinamide adenine dinucleotide levels in many cell ty
46 mal redox potential, associated with reduced nicotinamide adenine dinucleotide metabolism and altered
47 ion of 2',3'-cyclic phosphate-activated beta-nicotinamide adenine dinucleotide (NAD>p) and ACA>p RNA
48 resembling human fatty liver, lowers hepatic nicotinamide adenine dinucleotide (NAD(+) ) levels drivi
50 enzymes of redox reactions: oxidized/reduced nicotinamide adenine dinucleotide (NAD(+) and NADH) and
51 eously measure oxidized and reduced forms of nicotinamide adenine dinucleotide (NAD(+) and NADH), oxi
52 ruction program involving rapid breakdown of nicotinamide adenine dinucleotide (NAD(+)) after injury.
53 ypoxia produced PARP1-dependent depletion of nicotinamide adenine dinucleotide (NAD(+)) and inhibitio
54 s an enzyme that catalyses the hydrolysis of nicotinamide adenine dinucleotide (NAD(+)) and is a cand
55 a common intermediate in the biosynthesis of nicotinamide adenine dinucleotide (NAD(+)) and its deriv
57 ld access a Ru-H intermediate using oxidized nicotinamide adenine dinucleotide (NAD(+)) as the H(-) s
58 anscription feedback loop produces cycles of nicotinamide adenine dinucleotide (NAD(+)) biosynthesis,
60 yl guanosine (m(7)G) cap, a non-canonical 5' nicotinamide adenine dinucleotide (NAD(+)) cap can tag c
61 ver, mammalian mRNAs can also carry a 5' end nicotinamide adenine dinucleotide (NAD(+)) cap that, in
62 al demise is due to severe, neuron-specific, nicotinamide adenine dinucleotide (NAD(+)) depletion.
64 critical step in the de novo biosynthesis of nicotinamide adenine dinucleotide (NAD(+)) in mammals.
72 energy stress and oxidative stress response, nicotinamide adenine dinucleotide (NAD(+)) is emerging a
75 nzymes implicated in L-tryptophan/kynurenine/nicotinamide adenine dinucleotide (NAD(+)) metabolism, t
76 by interacting with L-tryptophan/kynurenine/nicotinamide adenine dinucleotide (NAD(+)) metabolism.
78 sfer of ADP-ribose from the oxidized form of nicotinamide adenine dinucleotide (NAD(+)) onto substrat
79 ich transitions to a proton-pumping Fd(red): nicotinamide adenine dinucleotide (NAD(+)) oxidoreductas
83 tinamide riboside (NR) is a newly discovered nicotinamide adenine dinucleotide (NAD(+)) precursor vit
84 preclinical studies showed the potential of nicotinamide adenine dinucleotide (NAD(+)) precursors to
85 sferase (NMNAT), an evolutionarily conserved nicotinamide adenine dinucleotide (NAD(+)) synthase and
87 high lactate production, and a high ratio of nicotinamide adenine dinucleotide (NAD(+)) to its reduce
88 a PTM, in which ADP-ribosyltransferases use nicotinamide adenine dinucleotide (NAD(+)) to modify tar
89 ction in the ratio of the amount of oxidized nicotinamide adenine dinucleotide (NAD(+)) to that of it
91 monstrate that cell-autonomous generation of nicotinamide adenine dinucleotide (NAD(+)) via the kynur
92 y, quantum dots (QDs) modified with cofactor nicotinamide adenine dinucleotide (NAD(+)) were prepared
94 Nicotinamide (NAM) is the main precursor of nicotinamide adenine dinucleotide (NAD(+)), a coenzyme e
95 er the ADP-ribose moiety from its substrate, nicotinamide adenine dinucleotide (NAD(+)), to amino aci
97 such factor is the sirtuin (SIRT) family of nicotinamide adenine dinucleotide (NAD(+))-dependent dea
98 resveratrol action is the activation of the nicotinamide adenine dinucleotide (NAD(+))-dependent dea
99 rients, which requires the activation of the nicotinamide adenine dinucleotide (NAD(+))-dependent dea
100 and the sirtuins as a conserved family of a nicotinamide adenine dinucleotide (NAD(+))-dependent pro
106 that KinA is activated by a decrease in the nicotinamide adenine dinucleotide (NAD(+))/NADH ratio vi
108 of renal recovery from injury by regulating nicotinamide adenine dinucleotide (NAD) biosynthesis.
112 ng NAD synthetase 1, the final enzyme of the nicotinamide adenine dinucleotide (NAD) de novo synthesi
113 e levels and was up-regulated in response to nicotinamide adenine dinucleotide (NAD) depletion and in
114 ing liver regeneration, the concentration of nicotinamide adenine dinucleotide (NAD) falls, at least
120 ation telomerase knockout mice display lower nicotinamide adenine dinucleotide (NAD) levels, and an i
121 be potent supplements boosting intracellular nicotinamide adenine dinucleotide (NAD) levels, thus pre
122 s the major determinant of dependence on the nicotinamide adenine dinucleotide (NAD) metabolic pathwa
123 (kcatc) for Rubisco from the C4 grasses with nicotinamide adenine dinucleotide (NAD) phosphate malic
125 n variants in HAAO or KYNU, two genes of the nicotinamide adenine dinucleotide (NAD) synthesis pathwa
126 SIRT1 and PARP1, that are each consumers of nicotinamide adenine dinucleotide (NAD), a metabolite in
128 Examples include the adduct of glutamate and nicotinamide adenine dinucleotide (NAD), fragments of NA
131 2 family of enzymes or sirtuins are known as nicotinamide adenine dinucleotide (NAD)-dependent deacet
132 Sirtuin 2 (SIRT2), one of the mammalian nicotinamide adenine dinucleotide (NAD)-dependent lysine
133 a class of enzymes originally identified as nicotinamide adenine dinucleotide (NAD)-dependent protei
137 bosyltransferases such as PARPs that utilize nicotinamide adenine dinucleotide (NAD+) as a cofactor t
140 cations, including the recently described 5' nicotinamide-adenine dinucleotide (NAD(+)) RNA in bacter
142 osphate [ADP]/adenosine monophosphate [AMP], nicotinamide adenine dinucleotide /NAD, nicotinamide ade
143 ly promoted ROS production by downregulating nicotinamide adenine dinucleotide(+) (NAD(+))/reduced fo
144 ed electron transfer (PCET) reaction between nicotinamide adenine dinucleotide (NADH) and a protein-b
145 ltammetric determination of cysteamine (CA), nicotinamide adenine dinucleotide (NADH) and folic acid
146 s and produce in situ chemical species (beta-nicotinamide adenine dinucleotide (NADH) and H2O2) actin
147 1 mediates reduction of the diiron center by nicotinamide adenine dinucleotide (NADH) and initiates O
148 cleic acids (AAA + NA), tryptophan residues, nicotinamide adenine dinucleotide (NADH) and vitamin A w
149 to pyruvate to form l-lactate, using reduced nicotinamide adenine dinucleotide (NADH) as the cofactor
150 le electrochemical sensing platform for beta-nicotinamide adenine dinucleotide (NADH) based on uncapp
152 rts was associated with a marked decrease in nicotinamide adenine dinucleotide (NADH) fluorescence, l
153 de adenine dinucleotide phosphate (NADPH) to nicotinamide adenine dinucleotide (NADH) have been made
154 e new sensor were tested by the oxidation of nicotinamide adenine dinucleotide (NADH) in a 0.1 M Robi
155 mediators for the oxidation of reduced beta-nicotinamide adenine dinucleotide (NADH) in two polymeri
158 l alcohol sensing, whereby the coenzyme beta-Nicotinamide adenine dinucleotide (NADH) is employed as
159 ith the intracellular application of reduced nicotinamide adenine dinucleotide (NADH), an effect that
160 ine spectral profiles of tryptophan, reduced nicotinamide adenine dinucleotide (NADH), and flavin den
161 se that is stimulated by the reduced form of nicotinamide adenine dinucleotide (NADH), suggesting a s
163 ew electrode material for the development of nicotinamide adenine dinucleotide (NADH)-based biosensor
168 We assessed the reduced/oxidized ratio of nicotinamide adenine dinucleotide (NADH/NAD(+) ratio) an
169 decreasing Complex I activity, elevating the nicotinamide adenine dinucleotide (NADH/NAD(+)) ratio an
170 intracellular lactate levels, disrupted the nicotinamide adenine dinucleotide (NADH/NAD(+)) ratio, a
171 s we measured the production rate of reduced nicotinamide adenine dinucleotides (NADH) from 91 potent
172 active oxygen species (ROS) by the phagocyte nicotinamide adenine dinucleotide (NADPH) oxidase in pat
177 nase 2 was reduced, whereas the NOX2 (NADPH [nicotinamide adenine dinucleotide phosphatase] oxidase s
178 phatase] oxidase subunit 2) and NOX4 (NADPH [nicotinamide adenine dinucleotide phosphatase] oxidase s
179 translocation of the cytosolic components of nicotinamide adenine dinucleotide phosphate (NAD(P)H)-ox
180 ADP by exchanging the nicotinamide moiety of nicotinamide adenine dinucleotide phosphate (NADP(+) ) f
181 e adenine dinucleotide (NAD(+) and NADH) and nicotinamide adenine dinucleotide phosphate (NADP(+) and
182 (+) and NADH), oxidized and reduced forms of nicotinamide adenine dinucleotide phosphate (NADP(+) and
185 oduction of reactive oxygen species (ROS) by nicotinamide adenine dinucleotide phosphate (NADPH) 2 (N
186 chemical analogue exploiting this principle, nicotinamide adenine dinucleotide phosphate (NADPH) and
187 dehyde as substrates and the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) as c
188 gulate the activity of dFB neurons through a nicotinamide adenine dinucleotide phosphate (NADPH) cofa
189 to support the synthesis and regeneration of nicotinamide adenine dinucleotide phosphate (NADPH) in p
191 is metabolism, reducing power in the form of nicotinamide adenine dinucleotide phosphate (NADPH) is r
192 blast function, activating integrin-mediated nicotinamide adenine dinucleotide phosphate (NADPH) oxid
193 8-mediated ROS was generated through reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxid
195 neutrophils exhibited reduced (hydrogenated) nicotinamide adenine dinucleotide phosphate (NADPH) oxid
196 this study, we show that antibiotics rescue nicotinamide adenine dinucleotide phosphate (NADPH) oxid
197 ure to LPS led to up-regulated expression of nicotinamide adenine dinucleotide phosphate (NADPH) oxid
199 sing intravital microscopy with mice lacking nicotinamide adenine dinucleotide phosphate (NADPH) oxid
200 ation of p47(phox) (an organizer subunit for nicotinamide adenine dinucleotide phosphate (NADPH) oxid
201 ng protein 9 (CARD9), but was independent of nicotinamide adenine dinucleotide phosphate (NADPH) oxid
202 because of defective activation of phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxid
203 s in the genes that encode components of the nicotinamide adenine dinucleotide phosphate (NADPH) oxid
205 causing hemolytic anemia linked to impaired nicotinamide adenine dinucleotide phosphate (NADPH) prod
206 s, G6PD is upregulated and generates reduced nicotinamide adenine dinucleotide phosphate (NADPH) that
207 cofactor specificity of oxidoreductases from nicotinamide adenine dinucleotide phosphate (NADPH) to n
209 the enzyme with acyl-coenzyme A and reduced nicotinamide adenine dinucleotide phosphate (NADPH), a p
210 l and cellular concentration of glutathione, nicotinamide adenine dinucleotide phosphate (NADPH), and
211 operoxidase (LPO) and myeloperoxidase (MPO), nicotinamide adenine dinucleotide phosphate (NADPH)-depe
212 vealed age-related changes in the density of nicotinamide adenine dinucleotide phosphate (NADPH)-diap
213 , which exhibited decreased steatohepatitis, nicotinamide adenine dinucleotide phosphate (NADPH)-oxid
214 icotinamide adenine dinucleotide phosphate / nicotinamide adenine dinucleotide phosphate , flavin ade
215 MP], nicotinamide adenine dinucleotide /NAD, nicotinamide adenine dinucleotide phosphate / nicotinami
216 rtas of wild-type mice or mice deficient for nicotinamide adenine dinucleotide phosphate [NAD(P)H] ox
217 ependent protein kinase II), which decreases nicotinamide adenine dinucleotide phosphate hydrogen syn
218 ore, post-R had significantly higher reduced nicotinamide adenine dinucleotide phosphate levels, redu
220 the STAT5/PI3K/Akt signalling axis and that nicotinamide adenine dinucleotide phosphate oxidase (NOX
221 rtate (NMDA) receptor-mediated activation of nicotinamide adenine dinucleotide phosphate oxidase (NOX
224 uced blood pressure, whereas the transfer of nicotinamide adenine dinucleotide phosphate oxidase 2-de
226 at adiponectin directly decreases myocardial nicotinamide adenine dinucleotide phosphate oxidase acti
227 rated that adiponectin suppresses myocardial nicotinamide adenine dinucleotide phosphate oxidase acti
228 nulomatous disease (CGD) is due to defective nicotinamide adenine dinucleotide phosphate oxidase acti
229 the signal involves plasma membrane reduced nicotinamide adenine dinucleotide phosphate oxidase acti
230 p47(phox) subunit beyond and independent of nicotinamide adenine dinucleotide phosphate oxidase acti
231 neuroinflammation by selectively inhibiting nicotinamide adenine dinucleotide phosphate oxidase and
232 the generation of reactive oxygen species by nicotinamide adenine dinucleotide phosphate oxidase and
233 blocked agonist-initiated association of the nicotinamide adenine dinucleotide phosphate oxidase comp
234 airment through neurohormonal activation of (nicotinamide adenine dinucleotide phosphate oxidase depe
235 ing the efficacy of an ultra-low dose of the nicotinamide adenine dinucleotide phosphate oxidase inhi
236 ), TEMPOL (a general antioxidant), apocynin (nicotinamide adenine dinucleotide phosphate oxidase inhi
239 ed baroreflex sensitivity is associated with nicotinamide adenine dinucleotide phosphate oxidase subu
241 xpression in P47 and Rac-1 expression of two nicotinamide adenine dinucleotide phosphate oxidase subu
242 own experimentally to activate transmembrane nicotinamide adenine dinucleotide phosphate oxidase type
243 th P67 dominant negative mice to inhibit the nicotinamide adenine dinucleotide phosphate oxidase were
246 show that the oxidative burst, catalyzed by nicotinamide adenine dinucleotide phosphate oxidase, can
247 cleotide phosphate oxidase 4 (Nox4), a major nicotinamide adenine dinucleotide phosphate oxidase, med
248 drial electron transport chain reactions and nicotinamide adenine dinucleotide phosphate oxidase, or
250 uncoupled endothelial nitric oxide synthase, nicotinamide adenine dinucleotide phosphate oxidase, xan
253 oding adiponectin) led to reduced myocardial nicotinamide adenine dinucleotide phosphate oxidase-deri
254 tion by restoring renal blood flow, reducing nicotinamide adenine dinucleotide phosphate oxidase-deri
256 n peroxide (H(2)O(2)), likely by stimulating nicotinamide adenine dinucleotide phosphate oxidase.
257 activation, implicating a crosstalk between nicotinamide adenine dinucleotide phosphate oxidases and
258 downstream effectors such as Rho kinase and nicotinamide adenine dinucleotide phosphate oxidases are
259 Dual oxidases (DUOX) are conserved reduced nicotinamide adenine dinucleotide phosphate oxidases tha
260 reased malondialdehyde, 3-nitrotyrosine, and nicotinamide adenine dinucleotide phosphate oxidases).
261 nship between two membrane transporters, the Nicotinamide adenine dinucleotide phosphate reduced form
262 tive was to investigate the possible role of nicotinamide adenine dinucleotide phosphate reduced form
263 e hypothesized that AGEs induce TACE through nicotinamide adenine dinucleotide phosphate reduced oxid
264 te to cardioprotection by generating reduced nicotinamide adenine dinucleotide phosphate to enhance b
265 of ribose and NADP(+) (the oxidized form of nicotinamide adenine dinucleotide phosphate) complexes o
266 NADPH/NADP(+) (the reduced form of NADP(+)/nicotinamide adenine dinucleotide phosphate) homeostasis
267 vascular wall include NADPH (reduced form of nicotinamide adenine dinucleotide phosphate) oxidase, xa
268 ial susceptibility to NADPH (reduced form of nicotinamide adenine dinucleotide phosphate) oxidase-dep
269 ing the cofactors adenosine triphosphate and nicotinamide adenine dinucleotide phosphate, and have be
270 derivatives in complex with PfIspC, reduced nicotinamide adenine dinucleotide phosphate, and Mg(2+)
271 ion, depleting and oxidizing glutathione and nicotinamide adenine dinucleotide phosphate, and signifi
272 osynthetic electron transport in the form of nicotinamide adenine dinucleotide phosphate, reduced are
273 , Shc expression, markers of senescence, and nicotinamide adenine dinucleotide phosphate, reduced for
274 nockout, PBL13 is able to associate with the nicotinamide adenine dinucleotide phosphate, reduced oxi
275 forms of nicotinamide adenine nucleotide and nicotinamide adenine dinucleotide phosphate, respectivel
279 e performed for acetylcholinesterase (AChE), nicotinamide adenine dinucleotide phosphate-diaphorase (
280 enchymal stem/stromal cell therapy decreased nicotinamide adenine dinucleotide phosphate-oxidase 2 an
283 for G6PD enzyme activity, cellular oxidized nicotinamide adenine dinucleotide phosphate/NADPH levels
284 olism via endogenous fluorescence of reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)
286 otein adducts together with increased NADPH (nicotinamide adenine dinucleotide phosphateoxidase) acti
287 mic reticulum on electron microscopy, and 3) nicotinamide adenine dinucleotide redox potential and ad
288 tathione/oxidized glutathione (GSH/GSSG) and nicotinamide adenine dinucleotide reduced/oxidized forms
289 ubunits of the RNA polymerase, and thylakoid nicotinamide adenine dinucleotide (reduced) and cytochro
290 hain reaction) and oxidative phosphorylation nicotinamide adenine dinucleotide (reduced) dehydrogenas
291 inactivate Sirt3 because of increased NADH (nicotinamide adenine dinucleotide, reduced form) and ace
292 ence of C-SWCNT, the oxidation of NADH (beta-nicotinamide adenine dinucleotide, reduced form) and DTT
293 e of ALDH7A1 activity, which generates NADH (nicotinamide adenine dinucleotide, reduced form) from NA
294 acetate production to the formation of NADH (nicotinamide adenine dinucleotide, reduced form) that is
295 esults in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD(
296 etabolic dependencies (fatty acid oxidation, nicotinamide adenine dinucleotide synthesis, glutamine b
297 witch, we demonstrated that depletion of the nicotinamide adenine dinucleotide synthetase (NadE) rapi
298 ms-ethanol by reducing the ratio of oxidized nicotinamide adenine dinucleotide to reduced nicotinamid
299 n catalysed by these enzymes is energized by nicotinamide adenine dinucleotide, which activates ubiqu
300 NA damage and consumes and depletes cellular nicotinamide adenine dinucleotide, which leads to mitoch